🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yeonil Kim

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0001-6788-4275

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2”.

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

Cancer(2020)10.1002/cncr.32855

N/A

1.0DataRank · unranked

30 citations

Elizabeth A. Mullen, James I. Geller, Yueh‐Yun Chi, Geetika Khanna, Richard D. Glick +7 more

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Cancer(2020)10.1002/cncr.33173

N/A

0DataRank · unranked

26 citations

Nicholas G. Cost, Yueh‐Yun Chi, Brett Tornwall, Mariana M. Cajaiba, Elizabeth J. Perlman +9 more

Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)

Cancer(2022)10.1002/cncr.34219

N/A

0DataRank · unranked

17 citations

Elizabeth J. Perlman, Brett Tornwall, Yueh‐Yun Chi, Yeonil Kim, Fredric A. Hoffer +16 more